EP3645034
21-DAY DOSING REGIMEN FOR FUSION PROTEINS COMPRISING FACTOR IX AND HUMAN ALBUMIN FOR PROPHYLACTIC TREATMENT OF HEMOPHILIA AND METHODS THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.6.2018EP published:
30.8.2023EP application number:
18736860.0
EPO information:
European Patent Register
Max expiry date:
28.6.2038
Title in English:
21-DAY DOSING REGIMEN FOR FUSION PROTEINS COMPRISING FACTOR IX AND HUMAN ALBUMIN FOR PROPHYLACTIC TREATMENT OF HEMOPHILIA AND METHODS THEREOFLanguage of the patent:
English
Timeline
Today
29.6.2018EP application
30.8.2023EP Publication
Owner
Name:
CSL Behring Lengnau AGAddress:
Biotech Innovation Park, 2543 Lengnau BE, CH
Inventor
Name:
LI, YanyanAddress:
Furlong, PA 18925, US
Name:
BENSEN-KENNEDY, DebraAddress:
Phoenixville, PA 19460, US
Name:
JACOBS, IrisAddress:
King of Prussia, PA 19406, US
Name:
VOIGT, ChristineAddress:
Devon, PA 19333, US
Priority
Number:
201762526377 PDate:
29.6.2017Country:
US
Classification
Categories:
A61K 38/48, C12N 9/64